Radiotracer Injection

DRUG5 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Massachusetts General Hospital

Conditions

Crohn DiseaseEndometriomaEndometriosisHepatic Cell CarcinomaHuntington DiseaseLiver CirrhosisPSCPortal Hypertension

Unknown Phase

Innovative Imaging and Cognitive BIOmarkers to Predict Huntington's Disease Progression

RecruitingNCT05808153

Assistance Publique - Hôpitaux de ParisHuntington Disease

Start: 2024-03-21End: 2027-02-02Target: 80Updated: 2024-05-07

PET/MRI of Primary Sclerosing Cholangitis

Not yet recruitingNCT06252610

Massachusetts General HospitalPSC

Start: 2026-08-10End: 2029-04-30Target: 10Updated: 2026-07-13

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

RecruitingNCT06252493

Massachusetts General HospitalCrohn Disease

Start: 2023-12-19End: 2029-12-19Target: 25Updated: 2026-03-12

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

RecruitingNCT06265272

Massachusetts General HospitalHepatic Cell Carcinoma, Liver Cirrhosis, Portal Hypertension

Start: 2023-12-10End: 2026-12-19Target: 45Updated: 2025-09-26

PET/MRI for Evaluation of Endometriosis

Enrolling by invitationNCT06377553

Massachusetts General HospitalEndometrioma, Endometriosis

Start: 2025-01-06End: 2029-05-03Target: 60Updated: 2026-03-12

Related Papers

Collagen-binding ⁶⁸Ga-CBP8 PET/MR in Deep Pelvic Endometriosis: First-in-human Application.

2026-07-14

Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn's disease.

2026-02-17